Honz Pharmaceutical Statistics

Total Valuation

SHE:300086 has a market cap or net worth of CNY 4.12 billion. The enterprise value is 4.62 billion.

Market Cap	4.12B
Enterprise Value	4.62B

Important Dates

The next confirmed earnings date is Thursday, April 23, 2026.

Earnings Date	Apr 23, 2026
Ex-Dividend Date	n/a

Share Statistics

SHE:300086 has 455.12 million shares outstanding. The number of shares has increased by 0.58% in one year.

Current Share Class	455.12M
Shares Outstanding	455.12M
Shares Change (YoY)	+0.58%
Shares Change (QoQ)	-0.16%
Owned by Insiders (%)	4.22%
Owned by Institutions (%)	0.45%
Float	311.89M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	9.47
PB Ratio	3.84
P/TBV Ratio	4.41
P/FCF Ratio	270.48
P/OCF Ratio	33.43
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-24.28
EV / Sales	10.60
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	302.77

Financial Position

The company has a current ratio of 0.67, with a Debt / Equity ratio of 0.45.

Current Ratio	0.67
Quick Ratio	0.21
Debt / Equity	0.45
Debt / EBITDA	n/a
Debt / FCF	31.90
Interest Coverage	-6.25

Financial Efficiency

Return on equity (ROE) is -16.80% and return on invested capital (ROIC) is -8.10%.

Return on Equity (ROE)	-16.80%
Return on Assets (ROA)	-3.92%
Return on Invested Capital (ROIC)	-8.10%
Return on Capital Employed (ROCE)	-8.77%
Weighted Average Cost of Capital (WACC)	6.23%
Revenue Per Employee	660,678
Profits Per Employee	-288,451
Employee Count	659
Asset Turnover	0.22
Inventory Turnover	1.07

Taxes

Income Tax	-4.00M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +87.58% in the last 52 weeks. The beta is 0.43, so SHE:300086's price volatility has been lower than the market average.

Beta (5Y)	0.43
52-Week Price Change	+87.58%
50-Day Moving Average	10.51
200-Day Moving Average	8.21
Relative Strength Index (RSI)	41.17
Average Volume (20 Days)	21,708,278

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, SHE:300086 had revenue of CNY 435.39 million and -190.09 million in losses. Loss per share was -0.42.

Revenue	435.39M
Gross Profit	227.15M
Operating Income	-124.30M
Pretax Income	-201.90M
Net Income	-190.09M
EBITDA	-72.86M
EBIT	-124.30M
Loss Per Share	-0.42

Full Income Statement

Balance Sheet

The company has 17.95 million in cash and 486.28 million in debt, giving a net cash position of -468.32 million or -1.03 per share.

Cash & Cash Equivalents	17.95M
Total Debt	486.28M
Net Cash	-468.32M
Net Cash Per Share	-1.03
Equity (Book Value)	1.07B
Book Value Per Share	2.31
Working Capital	-151.19M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 123.34 million and capital expenditures -108.10 million, giving a free cash flow of 15.24 million.

Operating Cash Flow	123.34M
Capital Expenditures	-108.10M
Free Cash Flow	15.24M
FCF Per Share	0.03

Full Cash Flow Statement

Margins

Gross margin is 52.17%, with operating and profit margins of -28.55% and -43.66%.

Gross Margin	52.17%
Operating Margin	-28.55%
Pretax Margin	-46.37%
Profit Margin	-43.66%
EBITDA Margin	-16.74%
EBIT Margin	-28.55%
FCF Margin	3.50%

Dividends & Yields

SHE:300086 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.58%
Shareholder Yield	-0.58%
Earnings Yield	-4.61%
FCF Yield	0.37%

Dividend Details

Stock Splits

The last stock split was on September 30, 2015. It was a forward split with a ratio of 1.5.

Last Split Date	Sep 30, 2015
Split Type	Forward
Split Ratio	1.5

Scores

SHE:300086 has an Altman Z-Score of 1.56 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.56
Piotroski F-Score	3